NEW MUTATION C.-140C>G IN 5’UTR OF ANKRD26 GENE IN PATIENTS WITH MILD FORM OF INHERITED THROMBOCYTOPENIA ASSOCIATED WITH MALIGNANCIES.

EHA Library, Fabrizio Fabris, 133389

MYCHOFENOLATE MOFETILE FOR THE TREATMENT OF CHILDREN WITH IMMUNE THROMBOCYTOPENIA AND EVANS SYNDROME. A RESTROSPECTIVE STUDY OF THE ITALIAN ASSOCIATION OF PEDIATRIC HEAMATOLOGY/ONCOLOGY GROUP

EHA Library, Maurizio Miano, 133390

SAFETY AND EFFICACY OF ELTROMBOPAG IN SPLENECTOMIZED AND NONSPLENECTOMIZED PATIENTS WITH IMMUNE THROMBOCYTOPENIA: RESULTS FROM THE EXTEND STUDY

EHA Library, Raymond Wong, 133391

CHARACTERIZATION OF PATIENTS WITH IMMUNE THROMBOCYTOPENIA (ITP) ENTERING REMISSION IN A ROMIPLOSTIM BONE MARROW STUDY

EHA Library, Ann Janssens, 133392

THE IMMUNOMODULATORY EFFECTS OF RETINIC ACID IN ADULT PATIENTS WITH IMMUNE THROMBOCYTOPENIA

EHA Library, Qi Feng, 133393

STUDIES ON PLATELET FUNCTION IN A GROUP OF CLL AND MCL PATIENTS TREATED WITH IBRUTINIB - PRELIMINARY RESULTS

EHA Library, Bozena Sokolowska, 133394

CLINICAL CHARACTERISTICS AND TREATMENT PATTERN OF NEWLY DIAGNOSED PRIMARY IMMUNE THROMBOCYTOPENIA CASES IN THE UNITED KINGDOM IMMUNE THROMBOCYTOPENIA (ADULT) REGISTRY

EHA Library, Umesh Doobaree, 133395

EFFICACY AND SAFETY OF RIVAROXABAN FOR NON-VALVULAR ATRIAL FIBRILLATION IN PATIENTS WITH SEVERE RENAL IMPAIRMENT

EHA Library, Sara Ali, 133396

ORAL DIRECT ANTICOAGULANTS IN THE TREATMENT OF NONVALVULAR ATRIAL FIBRILLATION. RESULTS OF THE DAILY CLINICAL PRACTICE

EHA Library, Beatriz Perez Villardon, 133397

SWITCH FROM VKA, LMWH OR FONDAPARINUX TO DOACS IN THE CLINICAL PRACTICE.

EHA Library, Francesco Cortiula, 133398

HIGH HEMOGLOBIN CONCENTRATIONS AND RISK OF THROMBOSIS: CAUSALITY OR CONFOUNDING?

EHA Library, Sæmundur Rögnvaldsson, 133399

HEMOSTATIC BIOMARKERS BASED PREDICTIVE MODEL FOR METASTATIC DISEASE, PROGRESSION AND MORTALITY IN CANCER PATIENTS

EHA Library, Elina Beleva, 133400

ANNEXIN A5 M2 HAPLOTYPE: TO BE OR NOT TO BE, THAT’S THE QUESTION!

EHA Library, Ana Rita TENREIRO PINTO, 133401

IRON METABOLISM IN PATIENTS WITH PORTAL THROMBOSES

EHA Library, Elena Lukina, 133402

PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER-RELATED VENOUS THROMBOSIS IN PATIENTS WITH HEMATOLOGICAL DISEASES

EHA Library, Ana Boban, 133403

EQUATIONS FOR ESTIMATING GFR: COMPARING RENAL FUNCTION CATEGORISATION IN THE CATCH STUDY

EHA Library, Mette Stagaard Janas, 133404

A PROSPECTIVE EVALUATION OF THE IMPACT OF TRANSFUSION DEPENDENCY ON QUALITY OF LIFE AND SYMPTOM BURDEN IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES

EHA Library, Giovanni Caocci, 133405

EFFECT OF LENALIDOMIDE PLUS LOW-DOSE DEXAMETHASONE TREATMENT UNTIL PROGRESSION ON HEALTH-RELATED QUALITY OF LIFE OVER TIME IN TRANSPLANT-INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Dan Vogl, 133406

HEALTHCARE COSTS AMONG NEWLY DIAGNOSED MULTIPLE MYELOMA (MM) PATIENTS UNDERGOING FRONTLINE STEM CELL TRANSPLANTATION IN THE U.S. – COMPARISON OF OUTPATIENT VERSUS INPATIENT-BASED CARE

EHA Library, Dorothy Romanus, 133407

COST-EFFECTIVENESS OF OFATUMUMAB FOR MAINTENANCE IN RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Andrew J. Davies, 133408

PATIENT PREFERENCES- SURVEY OF HODGKIN LYMPHOMA SURVIVORS ON TREATMENT-ASSOCIATED BURDEN AND SIDE EFFECTS

EHA Library, Carolin Buerkle, 133409

UNDERESTIMATED IMPACT OF MILD COGNITIVE IMPAIRMENT IN “CLINICALLY FIT” OLDER PATIENTS WITH MALIGNANT HEMOPATHIES ADMITTED TO RECEIVE CHEMOTHERAPY

EHA Library, Dominique BRON, 133410

WHAT DO PATIENT EXPERIENCE DATA REVEAL ABOUT THE DIAGNOSTIC JOURNEY FOR MYELOMA PATIENTS? FINDINGS FROM SECONDARY ANALYSIS OF NATIONAL CANCER PATIENT SURVEY DATA

EHA Library, Sarah Richard, 133411

STREAMLINING OF THE CHEMOTHERAPY SERVICE WITH FOCUS ON DRUG SUPPLY AND PATIENT SAFETY

EHA Library, Heike Reinhardt, 133412

INTERIM QUALITY OF LIFE RESULTS WITH VENETOCLAX (ABT-199/GDC-0199) MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY DEL(17P) CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Ling-I Hsu, 133413

RESULTS FROM ENESTOP: TREATMENT-FREE REMISSION (TFR) FOLLOWING SWITCH TO NILOTINIB (NIL) IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP)

EHA Library, Timothy Hughes, 135332

IMPACT OF CAPLACIZUMAB TREATMENT ON MORTALITY AND MAJOR THROMBOEMBOLIC EVENTS IN ACQUIRED TTP: PHASE II TITAN STUDY RESULTS

EHA Library, Qian Li, 135336

RUXOLITINIB COMPARED WITH BEST AVAILABLE THERAPY FOR ESSENTIAL THROMBOCYTHAEMIA PATIENTS RESISTANT OR INTOLERANT TO HYDROXYCARBAMIDE IN MAJIC - AN INVESTIGATOR LEAD RANDOMIZED TRIAL

EHA Library, Claire Harrison, 135335

STAT2 DEFICIENCY ENHANCES THE JAK2 V617F-INDUCED MPN THROMBOCYTOSIS PHENOTYPE: A NEW STAT PLAYER IN MYELOPROLIFERATIVE NEOPLASMS AND RELEVANCE TO INTERFERON TREATMENT

EHA Library, Christian Pecquet, 135334

THE H3K4 METHYLTRANSFERASE SETD1B IS ESSENTIAL FOR HAEMATOPOIETIC STEM CELL HOMEOSTASIS IN MICE

EHA Library, Kerstin Schmidt, 135333

AN OPEN-LABEL, RANDOMISED PHASE 3 STUDY OF DARATUMUMAB, LENALIDOMIDE, AND DEXAMETHASONE (DRD) VERSUS LENALIDOMIDE AND DEXAMETHASONE (RD) IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM): POLLUX

EHA Library, Meletios Dimopoulos, 135349

ETV6-RELATED THROMBOCYTOPENIA (ETV6-RT): CLINICAL AND PATHOGENETIC CHARACTERIZATION OF AN INHERITED THROMBOCYTOPENIA (IT) PREDISPOSING TO CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)

EHA Library, Federica Melazzini, 135181

PERSISTENCE OF DRIVER MUTATIONS DURING COMPLETE REMISSION ASSOCIATES WITH SHORTER SURVIVAL AND CONTRIBUTES TO THE INFERIOR OUTCOMES OF ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Maja Rothenberg-Thurley, 135179

STOPPING TYROSINE KINASE INHIBITORS IN A VERY LARGE COHORT OF EUROPEAN CHRONIC MYELOID LEUKEMIA PATIENTS: RESULTS OF THE EURO-SKI TRIAL

EHA Library, Johan Richter, 135178

Q&A and Panel Discussion

EHA Library, Faculty / Presenters, 141695

Infections in refugees

EHA Library, Gerd Fätkenheuer, 137057

The hematological spectrum of GATA2 mutations

EHA Library, Venetia Bigley, 137053

Sickle cell disease in Africa: Experience from Tanzania in clinical and genomic research

EHA Library, Julie Makani, 137050

New diseases on the European horizon: Sickle cell disease and thalassemia in refugees

EHA Library, Andreas E. Kulozik, 137056

Frequent medical problems in refugees

EHA Library, Christine Chomienne, 137055

Genomic analysis of inherited bone marrow failure and myelodysplastic syndrome

EHA Library, Ivo Touw, 137052

Thalassemias In South Asia

EHA Library, Anuja Premawardhena, 137049

José Carreras lecture: Towards understanding the anemia of myelodysplastic syndromes

EHA Library, Eva Hellström- Lindberg, 137047

EHA21 José Carreras award: Opening Ceremony

EHA Library, Andreas Engert, 137046

EHA21 Opening Ceremony: President's speech

EHA Library, Anthony Green, 137042

EHA21 Opening Ceremony: SPC Chair speech

EHA Library, Andreas Engert, 137043

CELL-EXTRINSIC HAEMATOPOIETIC IMPACT OF EZH2 INACTIVATION IN FOETAL LIVER ENDOTHELIAL CELLS

EHA Library, Wen Hao Neo, 135177

UPFRONT OR RESCUE TRANSPLANT IN YOUNG PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA: A POOLED ANALYSIS OF 529 PATIENTS

EHA Library, Francesca Gay, 135137

A GREATER UNDERLYING MUTATIONAL COMPLEXITY MAY CONTRIBUTE TO THE DIFFERENTIAL PROGNOSTIC IMPACT OF PHENOTYPIC-DRIVER MUTATION IN PRIMARY MYELOFIBROSIS

EHA Library, Paola Guglielmelli, 135147

PODOPLANIN EXPRESSION AND INTRAVASCULAR PLATELET AGGREGATES: THE MISSING LINK BETWEEN CANCER AND THROMBOSIS IN PRIMARY MALIGNANT BRAIN TUMORS

EHA Library, Julia Riedl, 135173

AKT ACTIVATION IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS PROMOTES TRANSFORMATION TOWARDS AGGRESSIVE RICHTER'S SYNDROME LYMPHOMA

EHA Library, Christian Pallasch, 135151

RAP-536 (MURINE ANALOG OF ACE-536/LUSPATERCEPT) INHIBITS SMAD2/3 SIGNALING AND PROMOTES ERYTHROID DIFFERENTIATION BY RESTORING GATA-1 FUNCTION IN A MURINE MODEL OF ?-THALASSEMIA

EHA Library, Pedro Martinez, 135169

THE IMPACT OF CELLULAR AGE ON LEUKEMIC TRANSFORMATION

EHA Library, Shahzya Chaudhury, 135155

OSTEONECROSIS AS A TREATMENT COMPLICATION IN HODGKIN LYMPHOMA PATIENTS: AN ANALYSIS OF THE GERMAN HODGKIN STUDY GROUP (GHSG)

EHA Library, Sven Borchmann, 135142

INDUCTION OF NA

EHA Library, Tzeon-Jye Chiou, 135160

COMPARISON OF 1690 MDS PATIENTS FROM THE EUROPEAN LEUKEMIANET REGISTRY AND REFERENCE POPULATIONS ? EVIDENCE FOR A SIGNIFICANT IMPAIRMENT IN QOL IN MDS AND DEFINITION OF PREDICTORS OF DIMINISHED QOL

EHA Library, Reinhard Stauder, 135165

LUSPATERCEPT INCREASES HEMOGLOBIN AND REDUCES TRANSFUSION BURDEN IN PATIENTS WITH LOW-INTERMEDIATE RISK MYELODYSPLASTIC SYNDROMES (MDS): LONG-TERM RESULTS FROM PHASE 2 PACE?MDS STUDY

EHA Library, Uwe Platzbecker, 135164

PET-CT ADAPTED THERAPY AFTER 3 CYCLES OF ABVD TO ALL STAGES OF HODGKIN LYMPHOMA. GATLA TRIAL HL-05.

EHA Library, Astrid Pavlovsky, 135141

MDSC (MYELOID-DERIVED SUPPRESSOR CELLS) DIFFERENTIATE UNDER GVHD (GRAFT-VERSUS-HOST DISEASE) CONDITIONS AND PREVENT GVHD BY INDUCING TYPE 2 T CELL RESPONSES

EHA Library, Gudrun Strauss, 135159

THE PYRUVATE KINASE ACTIVATOR AG-348 IMPROVES MURINE ?-THALASSEMIC ANEMIA AND CORRECTS INEFFECTIVE ERYTHROPOIESIS

EHA Library, Lucia de Franceschi, 135168

INTEGRATED ANALYSIS OF THE HUMAN HEMATOPOIETIC NON-CODING RNA LANDSCAPE REVEALS LNC-RNA STEM CELL SIGNATURE IN AML

EHA Library, Jan-Henning Klusman, 135154

A META-ANALYSIS OF OVERALL SURVIVAL IN PATIENTS WITH MULTIPLE MYELOMA TREATED WITH LENALIDOMIDE MAINTENANCE AFTER HIGH-DOSE MELPHALAN AND AUTOLOGOUS STEM CELL TRANSPLANT

EHA Library, Antonio Palumbo, 135136

MAJOR BLEEDING IN PATIENTS ON TREATMENT WITH NOAC OR VKA IN REAL-LIFE: CLINICAL PRESENTATION, MANAGEMENT AND OUTCOME

EHA Library, Laura Franco, 135172

ESTABLISHMENT OF A PRE-CLINICAL IN VIVO PLATFORM SPANNING LOW-RISK TO HIGH-RISK CLL

EHA Library, Gero Knittel, 135150

PHENOTYPIC DIFFERENCES AND TREATMENT RESPONSES IN MOLECULAR SUBGROUPS OF ESSENTIAL THROMBOCYTHEMIA FROM ANALYSIS OF THE PT1 COHORT

EHA Library, Jyoti Nangalia, 135146

INTERFERON ALPHA MEDIATED REMODELING OF THE BONE MARROW STEM CELL VASCULAR NICHE

EHA Library, Áine M Prendergast, 135176

THROMBOPOIETIN RECEPTOR AGONIST ELTROMBOPAG FOR ADVANCED MDS OR AML AND SEVERE THROMBOCYTOPENIA: 12-WEEK, RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 ASPIRE STUDY

EHA Library, Moshe Mittelman, 135163

WEEKLY CARFILZOMIB, CYCLOPHOSPHAMIDE AND DEXAMETHASONE (WKCYD) FOLLOWED BY MAINTENANCE WITH WEEKLY CARFILZOMIB (WK) IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM)

EHA Library, Sara Bringhen, 135135

ADJUSTMENT OF THERAPY FOR HODGKIN LYMPHOMA BASED ON INTERIM PET IS BENEFICIAL AND RADIOTHERAPY MAY BE SUBSTITUTED WITH CHEMOTHERAPY IN PATIENTS WITH NEGATIVE INTERIM STUDY: FINAL RESULTS OF H2 TRIAL

EHA Library, Eldad Dann, 135140

RUXOLITINIB PROVES SUPERIOR TO BEST AVAILABLE THERAPY IN PATIENTS WITH POLYCYTHEMIA VERA (PV) AND A NONPALPABLE SPLEEN: RESULTS FROM THE PHASE IIIB RESPONSE-2 STUDY

EHA Library, Francesco Passamonti, 135145

INCREASED REACTIVE OXYGEN SPECIES AND EXHAUSTION OF QUIESCENT CD34-POSITIVE BONE MARROW CELLS MAY CONTRIBUTE TO POOR GRAFT FUNCTION AFTER ALLOTRANSPLANT

EHA Library, Yuan Kong, 135158

SINGLE-CELL PROFILING OF HUMAN MEGAKARYOCYTE-ERYTHROID PROGENITORS IDENTIFIES DISTINCT MEGAKARYOCYTE AND ERYTHROID DIFFERENTIATION PATHWAYS

EHA Library, Beth Psaila, 135175

LONG-TERM FOLLOW-UP OF CONTEMPORARY TREATMENT IN EARLY-STAGE HODGKIN LYMPHOMA (HL): UPDATED ANALYSES OF THE GERMAN HODGKIN STUDY GROUP HD7, HD8, HD10 AND HD11 TRIALS

EHA Library, Paul J. Bröckelmann, 135139

DECODING THE RISK OF THROMBOEMBOLIC EVENTS IN LYMPHOMA PATIENTS

EHA Library, Darko Antic, 135171

IMPROVED EFFICACY AFTER INCORPORATING AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) INTO KRD TREATMENT WITH CARFILZOMIB (CFZ), LENALIDOMIDE (LEN), AND DEXAMETHASONE (DEX) IN NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Andrzej J. Jakubowiak, 135134

HIGH SYSTEMIC IRON LEVEL IS A RISK FACTOR FOR CARDIOVASCULAR DISEASE

EHA Library, Francesca Vinchi, 135167

CC-486 (ORAL AZACITIDINE) IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) WITH OR WITHOUT PRETREATMENT THROMBOCYTOPENIA

EHA Library, Guillermo Garcia-Manero, 135162

ACUTE MYELOID LEUKEMIA (AML) PATIENTS CURED AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION GENERATE TUMOR-SPECIFIC CYTOTOXIC ANTIBODIES THAT KILL AML BLASTS

EHA Library, Mette Hazenberg, 135157

HNRNP K: AN ONCOGENE AND TUMOR SUPPRESSOR, TWO DISCRETE PATHS TO AML THROUGH ON GENE

EHA Library, Miguel Gallardo, 135153

DISTINCT HOMOTYPIC B-CELL RECEPTOR INTERACTIONS SHAPE THE OUTCOME OF CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Paolo Ghia, 135149

INCREASED RISK OF SECOND MALIGNANCIES IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS DIAGNOSED IN SWEDEN 1973-2009 ? A POPULATION-BASED COHORT STUDY OF 9,379 PATIENTS

EHA Library, Anna Ravn Landtblom, 135144

BASELINE TOTAL METABOLIC VOLUME (TMTV) PREDICTS THE OUTCOME OF PATIENTS WITH ADVANCED HODGKIN LYMPHOMA (HL) ENROLLED IN THE AHL2011 LYSA TRIAL

EHA Library, Olivier CASASNOVAS, 135138

HUMAN HEMATOPOIETIC STEM CELL DIFFERENTIATION FOLLOWS A CONTINUOUS WADDINGTON-LIKE LANDSCAPE

EHA Library, Marieke Essers, 135174

ETHNICITY AND THE EPIDEMIOLOGY OF VENOUS THROMBOEMBOLISM: A POPULATION-BASED STUDY

EHA Library, Alejandro Lazo-Langner, 135170

CARFILZOMIB WEEKLY PLUS MELPHALAN AND PREDNISONE IN NEWLY DIAGNOSED ELDERLY MULTIPLE MYELOMA (IFM 2012-03)

EHA Library, Xavier Leleu, 135133

GENETIC LOSS OF ERYTHROID TFR2 STRONGLY AFFECTS THE THALASSEMIC PHENOTYPE IN MICE

EHA Library, Antonella Nai, 135166

ARCADE (20090160): A PHASE 3 RANDOMIZED PLACEBO-CONTROLLED DOUBLE-BLIND TRIAL OF DARBEPOETIN ALFA IN THE TREATMENT OF ANEMIA IN PATIENTS WITH LOW OR INTERMEDIATE-1 RISK MYELODYSPLASTIC SYNDROMES (MDS)

EHA Library, Uwe Platzbecker, 135161

NBEA: A NOVEL REGULATOR OF HEMATOPOIETIC STEM CELL IN VIVO REPOPULATION

EHA Library, Miguel Ganuza Fernandez, 135156

FREQUENT RECURRING MUTATIONS DISRUPT THE ANTI-PROLIFERATIVE FUNCTION OF ZBTB7AIN ACUTE MYELOID LEUKEMIA WITH T(8;21) TRANSLOCATION

EHA Library, Luise Hartmann, 135152

INTEGRATIVE ANALYSIS OF GENE MUTATIONS AND CHROMOSOMAL ABNORMALITIES BY NEXT-GENERATION SEQUENCING AND FISH IN HEMATOPOIETIC PROGENITORS OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Maria Hernandez Sanchez, 135148

OUTCOMES OF 121 PREGNANCIES IN PATIENTS WITH POLYCYTHEMIA VERA (PV)

EHA Library, Martin Griesshammer, 135143

Q&A and Panel Discussion

EHA Library, Faculty / Presenters, 141358

Antidotes for novel oral anticoagulants

EHA Library, Jean Marie Connors, 137041

HTS for IG and TR repertoire studies in lymphoproliferative diseases

EHA Library, Kostas Stamatopoulos, 137037

HTS for minimal residual disease in lymphoid malignancies

EHA Library, Monika Brüggemann, 137036

When and how to test for heparin-induced thrombocytopenia (HIT) antibodies?

EHA Library, Yves Gruel, 137040

Bioinformatic strategies for HTS data analysis

EHA Library, Nikos DARZENTAS, 137035

Introduction: Strategies for HTS of IG-TR genes: Possibilities and limitations

EHA Library, Anton Langerak, 137034

Genomics and NGS in thrombosis

EHA Library, Pieter Reitsma, 137039

Drug induced immune thrombocytopenia

EHA Library, Tamam Bakchoul, 137030